Svirski B, Edoute Y
Medical Dept. C, Rambam Medical Center, Haifa.
Harefuah. 1996 May 15;130(10):678-80, 727.
3 patients with recurrent, symptomatic hypoglycemia associated with increased insulin and C-peptide blood levels are described. 2 men aged 37 and 21-years had mental and social problems and although they had access to sulfonylurea drugs, both denied intake. 1 was scheduled for pancreatectomy, but as a result of the vigilance of the surgeon, the operation was canceled. By demonstrating sulfonylurea in their urine, a definitive diagnosis of factitious hypoglycemia was established, and further invasive procedures were avoided. The third was a woman aged 40-years had malignant insulinoma with liver metastases, proven by cytology. The common and differentiating clinical and laboratory characteristics of hypoglycemia due to insulinoma and factitious hypoglycemia secondary to sulfonylurea intake are discussed, and the importance of urine analysis demonstrating the presence of sulfonylurea is emphasized.
本文描述了3例复发性、症状性低血糖患者,其胰岛素和C肽血水平升高。2名年龄分别为37岁和21岁的男性存在精神和社会问题,尽管他们能够获得磺脲类药物,但两人均否认服用过。其中1例计划进行胰腺切除术,但由于外科医生的警惕,手术被取消。通过在他们的尿液中检测到磺脲类药物,确诊为人为性低血糖,避免了进一步的侵入性检查。第3例是一名40岁的女性,经细胞学证实患有恶性胰岛素瘤并伴有肝转移。文中讨论了胰岛素瘤所致低血糖和磺脲类药物摄入继发的人为性低血糖的常见及鉴别临床和实验室特征,并强调了尿液分析显示磺脲类药物存在的重要性。